Latest Breaking News On - Chief product development officer - Page 12 : comparemela.com
Harrison s Cave reopens after 16-month hiatus
barbadostoday.bb - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from barbadostoday.bb Daily Mail and Mail on Sunday newspapers.
Harrison Cave back in business - Barbados Today
barbadostoday.bb - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from barbadostoday.bb Daily Mail and Mail on Sunday newspapers.
Greetings and welcome to the Catalyst Pharmaceuticals First Quarter 2021 Results Conference Call. [Operator Instructions]
It is now my pleasure to introduce your host, Ms. Alicia Grande, Vice President, Chief Financial Officer and Treasurer. Thank you. You may begin.
Alicia Grande
Vice President, Chief Financial Officer and Treasurer
Good morning, everyone, and thank you for joining our conference call to discuss Catalyst s first quarter 2021 financial results and corporate highlights. Leading the call today, we have Patrick McEnany, Chairman and Chief Executive Officer. We are joined by Dr. Steven Miller, Chief Operating Officer and Chief Scientific Officer, and Jeffrey Del Carmen, Chief Commercial Officer. For the question and for the Q&A session, we also have Dr. Gary Ingenito, Chief Medical and Regulatory Officer.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Catalyst Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Business Update
Catalyst Pharmaceuticals, Inc.May 10, 2021 GMT
-Firdapse® Q1 2021 Net Revenues of $30.2 Million
-First Quarter 2021 GAAP Net Income of $7.7 Million; Non-GAAP Net Income of $11.6 Million
-Recently Received Orphan Drug Designation for Firdapse® in Japan
-$143.3 Million in Cash and Investments and no Funded Debt at end of Q1-2021
-Catalyst to Host Quarterly Conference Call at 8:30 AM ET Tomorrow
CORAL GABLES, Fla., May 10, 2021 (GLOBE NEWSWIRE) Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel high-quality medicines for patients living with rare diseases, today reported financial results for the first quarter ended March 31, 2021 and provided a business
EvoNexus Teams with Qualcomm & Verizon to Accelerate 5G Use Case Innovations
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.